What is Supernus Pharmaceuticals's components?

Supernus Pharmaceuticals (SUPN) reported components of $31.47M in Q1 2026.

What does components mean?

This represents a granular breakdown or specific sub-category of a larger financial statement line item. It is used to provide transparency into the composition of complex balance sheet or income statement accounts. Investors analyze these components to understand the underlying drivers of specific financial performance metrics.

Supernus Pharmaceuticals SUPN Components

Components at other companies

Praxis Precision Medicines, Inc.PRAX

——

Other financials

Income statement

See full

Revenue$207.7M+38.6%

Gross profit$184.3M+37.5%

Operating income-$8.3M+18.8%

Net income-$2.3M+80.6%

EPS (diluted)-$0.04+81.0%

Balance sheet

See full

Cash & equivalents$186.3M+60.8%

Total debt$40.9M+26.6%

Total equity$1.1B+4.5%

Total assets$1.5B+11.4%

Cash flow

See full

Operating cash flow$66.5M+117%

CapEx--100%

Free cash flow$66.5M+120%

Valuation

See full

Market cap$2.58B+62.8%

Enterprise value$2.44B+62.3%

P/S3.3×+0.9×

Profitability

See full

Gross margin89.4%+1.0pp

Operating margin-7.8%-18.9pp

Net margin-3.7%-13.0pp

FCF margin27.9%+3.4pp

Returns & leverage

See full

Return on equity-2.8%-9.1pp

Debt / equity0×0.0×

Current ratio2×-0.5×

Where this comes from

Reported directly by Supernus Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:InventoryRawMaterialsAndPurchasedPartsNetOfReserves.

The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Supernus Pharmaceuticals's components.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Supernus Pharmaceuticals's components?: Supernus Pharmaceuticals (SUPN) reported components of $31.47M in Q1 2026.
What does components mean?: This represents a granular breakdown or specific sub-category of a larger financial statement line item. It is used to provide transparency into the composition of complex balance sheet or income statement accounts. Investors analyze these components to understand the underlying drivers of specific financial performance metrics.